These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12164090)

  • 1. Improvement of endothelial function by amlodipine and vitamin C in essential hypertension.
    On YK; Kim CH; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS
    Korean J Intern Med; 2002 Jun; 17(2):131-7. PubMed ID: 12164090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiotensin converting enzyme inhibitor and calcium antagonist on endothelial function in patients with essential hypertension.
    On YK; Kim CH; Oh BH; Lee MM; Park YB
    Hypertens Res; 2002 May; 25(3):365-71. PubMed ID: 12135314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension.
    Taddei S; Virdis A; Ghiadoni L; Magagna A; Favilla S; Pompella A; Salvetti A
    Hypertension; 2001 Mar; 37(3):943-8. PubMed ID: 11244022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.
    Taddei S; Virdis A; Ghiadoni L; Magagna A; Salvetti A
    Circulation; 1998 Jun; 97(22):2222-9. PubMed ID: 9631871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of amlodipine and S(-)-amlodipine on vascular endothelial function in patients with hypertension.
    He Y; Si D; Yang C; Ni L; Li B; Ding M; Yang P
    Am J Hypertens; 2014 Jan; 27(1):27-31. PubMed ID: 23959544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function.
    Higashi Y; Sasaki S; Nakagawa K; Matsuura H; Kajiyama G; Oshima T
    J Am Coll Cardiol; 2001 Mar; 37(3):863-70. PubMed ID: 11693763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valsartan improves endothelial dysfunction in hypertension: a randomized, double-blind study.
    Tzemos N; Lim PO; MacDonald TM
    Cardiovasc Ther; 2009; 27(3):151-8. PubMed ID: 19604249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of valsartan or amlodipine on endothelial function and oxidative stress after one year follow-up in patients with essential hypertension.
    Hirooka Y; Kimura Y; Sagara Y; Ito K; Sunagawa K
    Clin Exp Hypertens; 2008 Apr; 30(3):267-76. PubMed ID: 18425706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of AT1 receptor blockade on endothelial function in essential hypertension.
    Klingbeil AU; John S; Schneider MP; Jacobi J; Handrock R; Schmieder RE
    Am J Hypertens; 2003 Feb; 16(2):123-8. PubMed ID: 12559678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients.
    Schiffrin EL; Pu Q; Park JB
    Am J Hypertens; 2002 Feb; 15(2 Pt 1):105-10. PubMed ID: 11863244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ghrelin restores nitric oxide availability in resistance circulation of essential hypertensive patients: role of NAD(P)H oxidase.
    Virdis A; Duranti E; Colucci R; Ippolito C; Tirotta E; Lorenzini G; Bernardini N; Blandizzi C; Taddei S
    Eur Heart J; 2015 Nov; 36(43):3023-30. PubMed ID: 26224075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients.
    Virdis A; Ghiadoni L; Qasem AA; Lorenzini G; Duranti E; Cartoni G; Bruno RM; Bernini G; Taddei S
    Eur Heart J; 2012 Jun; 33(12):1530-8. PubMed ID: 22450428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amlodipine improves vascular function in patients with moderate to severe hypertension.
    Ohtsuka S; Yamazaki A; Oyake Y; Yamaguchi I
    J Cardiovasc Pharmacol; 2003 Aug; 42(2):296-303. PubMed ID: 12883335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibition, but not calcium antagonism, improves a response of the renal vasculature to L-arginine in patients with essential hypertension.
    Higashi Y; Oshima T; Sasaki S; Nakano Y; Kambe M; Matsuura H; Kajiyama G
    Hypertension; 1998 Jul; 32(1):16-24. PubMed ID: 9674632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study.
    Higashi Y; Sasaki S; Nakagawa K; Ueda T; Yoshimizu A; Kurisu S; Matsuura H; Kajiyama G; Oshima T
    J Am Coll Cardiol; 2000 Feb; 35(2):284-91. PubMed ID: 10676671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-arterial vitamin C prevents endothelial dysfunction caused by ischemia-reperfusion.
    Pleiner J; Schaller G; Mittermayer F; Marsik C; MacAllister RJ; Kapiotis S; Ziegler S; Ferlitsch A; Wolzt M
    Atherosclerosis; 2008 Mar; 197(1):383-91. PubMed ID: 17645881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of antihypertensive therapy on responsiveness to local intra-arterial NG-monomethyl-L-arginine in patients with essential hypertension.
    Lyons D; Webster J; Benjamin N
    J Hypertens; 1994 Sep; 12(9):1047-52. PubMed ID: 7852748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms responsible for endothelial dysfunction induced by fasting hyperhomocystinemia in normotensive subjects and patients with essential hypertension.
    Virdis A; Ghiadoni L; Cardinal H; Favilla S; Duranti P; Birindelli R; Magagna A; Bernini G; Salvetti G; Taddei S; Salvetti A
    J Am Coll Cardiol; 2001 Oct; 38(4):1106-15. PubMed ID: 11583890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correction of endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus during combined antihypertensive therapy].
    Statsenko ME; Derevianchenko MV
    Ter Arkh; 2014; 86(8):90-3. PubMed ID: 25306751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
    Morimoto S; Yano Y; Maki K; Iwasaka T
    J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.